{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:51:34Z","timestamp":1769007094095,"version":"3.49.0"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,3]]},"DOI":"10.18632\/oncotarget.8489","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:42Z","timestamp":1459382442000},"page":"26709-26723","source":"Crossref","is-referenced-by-count":24,"title":["Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Wu","family":"Luo","sequence":"first","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Song","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Lei","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Feng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Zhang","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325035, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Rong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Guangzhou Women and Children's Medical Center, Guangzhou, 510623, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Peng","family":"Tan","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Mian","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Zhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Kun","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325035, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ping","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Tissue Transplantation and Immunology, Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Key Laboratory of Molecule Immunology and Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, 510632, China"},{"name":"School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, 325035, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","article-title":"The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype","volume":"88","author":"Melo","year":"1996","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1172\/JCI31691","article-title":"Treatment for chronic myelogenous leukemia: the long road to imatinib","volume":"117","author":"Hunter","year":"2007","journal-title":"J Clin Invest"},{"key":"3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5858\/2006-130-669-IROAO","article-title":"Imatinib resistance: obstacles and opportunities","volume":"130","author":"Litzow","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.V95.5.1758.005a41_1758_1766","article-title":"Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification","volume":"95","author":"Gambacorti-Passerini","year":"2000","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Sawyers","year":"2001","journal-title":"Science"},{"key":"6","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-03-080689","article-title":"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance","volume":"110","author":"Weitzman","year":"2007","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1158\/1078-0432.CCR-08-0308","article-title":"Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib","volume":"14","author":"Pazdur","year":"2008","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00277-010-1039-5","article-title":"Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients","volume":"90","author":"Huang","year":"2011","journal-title":"Ann Hematol"},{"key":"9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.leukres.2013.12.025","article-title":"BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome","volume":"38","author":"Ankathil","year":"2014","journal-title":"Leuk Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00277-006-0171-8","article-title":"Not all imatinib resistance in CML are BCR-ABL kinase domain mutations","volume":"85","author":"Wadenvik","year":"2006","journal-title":"Ann Hematol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood-2014-08-588855","article-title":"shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance","volume":"125","author":"Shacham","year":"2015","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clml.2013.11.002","article-title":"Second-line therapy for patients with chronic myeloid leukemia resistant to first-line imatinib","volume":"14","author":"Seiter","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Yu","year":"2014","journal-title":"Curr Pharm Des"},{"key":"14","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","article-title":"MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models","volume":"101","author":"Melo","year":"2003","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.leu.2403257","article-title":"P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate","volume":"18","author":"Schleyer","year":"2004","journal-title":"Leukemia"},{"key":"16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bours","year":"2003","journal-title":"Oncogene"},{"key":"17","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1038\/sj.onc.1204950","article-title":"Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation","volume":"20","author":"Kloog","year":"2001","journal-title":"Oncogene"},{"key":"18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1091\/mbc.e07-10-1053","article-title":"Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters","volume":"19","author":"Kloog","year":"2008","journal-title":"Mol Biol Cell"},{"key":"19","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1158\/1078-0432.CCR-11-3348","article-title":"Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2","volume":"18","author":"Sun","year":"2012","journal-title":"Clin Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<805::AID-CNCR16>3.0.CO;2-E","article-title":"Multidrug resistance protein expression in chronic myeloid leukemia: associations and significance","volume":"86","author":"Albitar","year":"1999","journal-title":"Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.blre.2015.08.001","article-title":"Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia","volume":"30","author":"Macias","year":"2016","journal-title":"Blood Rev"},{"key":"22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1158\/1541-7786.MCR-08-0297","article-title":"Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons","volume":"7","author":"Chen","year":"2009","journal-title":"Mol Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/1078-0432.CCR-10-1824","article-title":"Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1\/CCL2 expression","volume":"17","author":"Chen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"e90476","DOI":"10.1371\/journal.pone.0090476","article-title":"Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"key":"25","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1158\/0008-5472.CAN-13-3013","article-title":"Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation","volume":"74","author":"Navarro","year":"2014","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1074\/jbc.M311183200","article-title":"Presentation of galectin-1 by extracellular matrix triggers T cell death","volume":"279","author":"Baum","year":"2004","journal-title":"J Biol Chem"},{"key":"27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00418-008-0395-x","article-title":"Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes","volume":"129","author":"Walzel","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.cdd.4400708","article-title":"Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2","volume":"7","author":"Riera","year":"2000","journal-title":"Cell Death Differ"},{"key":"29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.cdd.4401485","article-title":"Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death","volume":"11","author":"Baum","year":"2004","journal-title":"Cell Death Differ"},{"key":"30","doi-asserted-by":"crossref","first-page":"41282","DOI":"10.1074\/jbc.M306624200","article-title":"Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis","volume":"278","author":"Cummings","year":"2003","journal-title":"J Biol Chem"},{"key":"31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1582-4934.2008.00506.x","article-title":"Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity","volume":"14","author":"Li","year":"2010","journal-title":"J Cell Mol Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1349-7006.2010.01501.x","article-title":"Mechanism of antitumor effect of a novel bFGF binding peptide on human colon cancer cells","volume":"101","author":"Wu","year":"2010","journal-title":"Cancer Sci"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T18:16:09Z","timestamp":1655403369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":32,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016,5,3]]}},"alternative-id":["8489","27050374"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8489","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]}}}